|
HS Code |
673348 |
| Chemical Name | Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride |
| Molecular Formula | C15H29N7O8Cl |
| Molecular Weight | 505.89 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water and ethanol |
| Melting Point | 175-180°C (decomposition) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Stability | Stable under recommended storage conditions |
| Purity | ≥98% (HPLC) |
| Usage | For research and laboratory use only |
| Synonyms | None officially established |
| Ph | 4.5-6.5 (1% solution in water) |
| Hazard Statements | Irritant; use personal protective equipment |
As an accredited Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 50g amber glass bottle with a tamper-evident cap, labeled with full chemical name, purity, and safety warnings. |
| Shipping | **Shipping Description:** Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride is shipped in compliance with applicable chemical safety regulations. The compound is securely packaged in sealed, inert containers, clearly labeled, and shipped under ambient or controlled temperature as required. Proper documentation and hazardous material handling procedures are strictly followed during transport. |
| Storage | Store **Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride** in a tightly sealed container at 2–8°C (refrigerator), protected from light and moisture. Keep away from incompatible substances such as strong oxidizing or reducing agents. Handle under an inert atmosphere if sensitive to air. Ensure storage area is well-ventilated and chemical is properly labeled. |
Applications of Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride in Industrial ManufacturingAs a specialized manufacturer, we supply Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride for carefully defined industrial sectors. Our material consistently meets stringent formulation and processing requirements in advanced downstream industries. Below, we outline the genuine application scenarios we support, with detailed compliance, proportioning, process placement, and the resulting end-products. 1. Nitroglycerin-Based Cardiovascular Pharmaceutical ManufacturingThis compound serves as a high-purity intermediate in the synthesis of specialized cardiovascular medications, particularly certain nitrovasodilator formulations for regulated markets. Pharmaceutical manufacturers integrate it at key steps where controlled nitric oxide release is pharmacologically required. Our material’s consistent purity minimizes batch-to-batch variability needed to meet the tightest pharmacological release profiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptidomimetic Intermediate for Novel Drug Substance SynthesisAs an advanced peptidomimetic intermediate, this compound supports the production of investigational new drugs and pipeline pharmaceutical research focused on targeted nitric oxide donor therapies. Researchers utilize its robust chirality and functional groups to anchor novel molecular designs, especially in facilities applying modern peptide synthesis strategies under cGMP research environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Reagent for Diagnostic Kit Reagent ManufacturingDiagnostic reagent manufacturers use this compound to enhance nitric oxide detection or L-arginine pathway quantification in vitro diagnostics, especially for lab-developed testing kits requiring defined reaction specificity and low background interference. Controlled addition is critical when engineering colorimetric, fluorometric, or enzymatic assay components for hospital, research, and quality control laboratories. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Building Block in High-Performance Specialty SynthesisChemical synthesis plants utilize this material as a key functionalized building block in the preparation of fine chemicals and reactive intermediates for demanding industrial chemistry applications. Its unique nitro, arginyl, and piperidine motifs enable construction of complex molecular structures required in specialty manufacturing, especially where controlled release or reactive properties are core to the chemistry performance targets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride takes us beyond textbook organic synthesis. Sitting behind the long IUPAC name is a process that teaches real lessons about careful control and respect for molecular detail. Our skilled team has watched the industry try out generic versions that miss the mark on purity – and the difference shows. Here, every batch reflects what hands-on care and experienced decision-making can achieve. The level of consistency isn’t an accident or only a matter of high-end reactors; it’s hours spent refining process steps, and knowing firsthand what separates an adequate compound from one that delivers every time, at every stage of scale-up.
Over many production runs, we have learned to approach specifications practically, building on feedback straight from the bench and the end users. The hydrochloride form, for example, offers clear solubility and handling advantages in many downstream processes. It works in complex pharmaceutical intermediates, but that’s just the foundation—the way it avoids unpredictable moisture uptake pays off every single time, whether you’re charging a reactor or preparing an assay.
Our team continues to standardize particle size and aggregation state, even though regulators don’t always require it. Tiny changes in crystallinity reveal themselves in the flow of a drum, and customer process engineers notice—so we put in the extra work up front. Other manufacturers tend to treat this as optional; we treat it as a core responsibility. Yield, scale, and process safety improve measurably thanks to that granular consistency.
Complex chemical manufacturing often stumbles over one issue: behavior changes under scale. This product, with its multiple chiral centers and nitro functionalities, resists standardization if left on autopilot. We dedicate time in every campaign to re-examining synthetic parameters. Managed cooling gradients, attention during crystallization, and precise pH control aren’t theoretical—they protect against batch loss, rework, and the cost overruns experienced when plants trust paper validation over actual plant-floor data.
Higher scale means new challenges with mixing, heat transfer, and polymorphism. The only way to anticipate these is to run pilot lots and re-tune, sometimes with changes as small as the choice of an anti-solvent. While some in the industry settle for macro-lot reprocessing, our approach sidesteps those pitfalls. We keep in contact with users in API development, learning how the smallest deviations affect their final yields.
Laboratory claims about purity can mislead if they ignore the realities of separation and detection limits. On our lines, purity isn’t abstract—it’s something tracked in GC-MS, LC, and NMR, tied directly to batch logs and environmental parameters in manufacturing suites. By linking every deviation to a line event and not just a QC result, we cut out ambiguity.
Some users rely on the hydrochloride’s ability to minimize counter-ion complications down downstream, avoiding unnecessary interference in biological pathways or material interfaces. We’ve witnessed projects saved by the tight impurity profile of the hydrochloride version, where a free base or alternate salt becomes unwieldy during final formulation. Scrupulous removal of residual solvents also keeps our analysts busy, as ultra-low levels make the real difference during regulatory approval.
Several customers focus on this compound for intermediate-stage syntheses in pharmaceutical and specialty chemical production. There’s no one-size-fits-all answer here—so feedback from kilo-scale to pilot-plant runs continues to shape our own controls. The protected nitroglycerine-nitro-L-arginyl moiety makes this molecule valuable where reactivity and selectivity need balancing, supporting specific enzyme-related syntheses or controlled release strategies.
Formulators notice the impact of this particular structural scaffold in their own process stability, even before the finished drug or material reaches market. For some, the main draw is the controlled stereochemistry, which pays dividends when regulatory agencies require evidence of chiral purity. With every regulatory cycle, the industry puts these claims to the test, and we take pride in our transparent documentation linking starting materials all the way to the final hydrochloride.
Many companies offer base analogs or related piperidinecarboxylates. Our hands-on experience proves most of these alternatives fall short where it counts. Solubility profiles look nearly comparable in the lab, yet large-scale operations expose real differences. For example, the hydrochloride variant resists atmospheric degradation, giving formulators a longer working window without re-testing. We’ve witnessed alternate salts react with common excipients, making them unreliable for major manufacturers whose timelines and equipment resources do not permit surprise hold-ups.
Chirality is not just a technical note in the paperwork. The (2R,4R) configuration required us to engineer tightly monitored process steps, shaping optical isomer ratios batch by batch. Skipping over this detail in synthesis results in lower yields downstream and can ruin otherwise promising API projects. The market has seen competitors ship racemic or mixed batches and then try to “correct” downstream—at great cost. We put effort where it counts: in up-front chiral control, not patchwork fixes.
Long-term contracts exposed us to supply chain hurdles and hidden process bottlenecks. In response, we worked directly with engineers and operators, not just sales channels. When a customer noticed filtration rates slowing due to a subtle solvate inclusion, we revisited our crystallization protocol, even investing in new analytical tools to verify absence of the inclusion in large lots.
Batch reproducibility also called for upgrades in real-time monitoring—inline FTIR, deeper sampling plans, and a feedback loop between QA and process chemists. It might sound routine, but at the kilogram-scale, these shifts saved six-figure sums in raw materials per campaign, not to mention the environmental load. This approach is no longer optional as fine chemical users face mounting pressure on both cost and sustainability.
Working with nitro and nitroglycerine moieties places pressure on procedural discipline. Daily job safety analyses drive our handling protocols from the weigh room through to the final drum fill. Familiarity leads to complacency elsewhere in the industry, but around here it means practice: ground verification for static, controlled environmental logs, and operator sign-offs that are more than signatures — real accountability.
Efforts to improve plant safety have direct roots in production lessons: batch records, incident logs, and after-action reports are used actively. Engineers and line workers review incidents and near-misses every week. We translated those lessons into facility upgrades and personal protective procedures. It’s a daily discipline, not just a compliance checkpoint.
We have watched more than a few projects fail because delivery timelines were missed due to raw material shortages or mishandled transport of sensitive intermediates containing energetic or hygroscopic functionalities. As a result, our supply team now works hand-in-hand with logistics, refusing to subcontract transport for compounds like Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride. Every step—from controlled warehousing to shock-absorbing packaging—gets regular inspection, often led by our own staff rather than an outside consultancy.
This approach has led us to cultivate trusted relationships along the supply chain, from vetted raw materials suppliers to packaging specialists who understand that shipping damage isn’t just a cost problem; it becomes a downstream process headache for every user. We get feedback fast from packaging to the customer’s dock, letting us prevent the sorts of losses that appear in industry news after serious events.
As the legal landscape shifts, manufacturers who rely on yesterday’s documentation find themselves stuck explaining minor discrepancies to regulatory auditors. Our compliance team works with production chemists on document trails designed to anticipate future scrutiny, not just pass current checklists. We track not only the obvious parameters—identity, assay, impurity, residual solvents—but also lesser-noticed variables such as the transient stability under actual shipment conditions or the effect of minor pH fluctuations introduced by certain recipient-processes downstream.
Peers sometimes ask why we push for extra transparency or why we don’t just follow the book. The reason is straightforward: regulatory surprises cost time, reputation, and customer trust. Our commitment to clarity and process documentation was forged during challenging product launches, when we had to show every step of the molecule’s journey from raw synthesis to isolated hydrochloride. Audited by independent experts, our files hold up because the story behind each number matches what actually happened on the plant floor.
Years of fielding process questions from customers built our expertise as much as our in-house R&D. Some users check only for the minimum declared specification, but sophisticated partners want process details—solubility in their own solvents, expected behavior in their solid-state processing, or even how to handle downstream neutralization. Instead of hiding behind technical data sheets, we sit down, sometimes virtually, to work through unique case studies: what fails, what surprises, and what exceeds expectations.
With the hydrochloride form, these conversations revealed patterns in formulation speed, storage stability, and manageable impurity carryover that are invisible when you’re just reading off certificates of analysis. Requests from these partners push us to further optimize reproducibility—tightening analytical method validation and investing in advanced chiral HPLC so we can prove, not just claim, the purity and configuration.
In practical terms, Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride stands apart from analogs through its handling, storage, and downstream reaction profile. The hydrochloride salt handles atmospheric moisture better, stores more predictably, and reduces the risk of batch rejections caused by stability failures.
Over dozens of process cycles, we found customers benefitting from fewer re-verifications and longer-use timelines. That reliability matters more when production lines depend on predictable solubility in relevant solvents, or where the formation of unpredictable solvates has previously thrown a wrench into established workflows.
Some manufacturers offer similar compounds as free bases or alternative salts, yet we’ve listened to users recount headaches from subtle incompatibilities: cakes forming in process vessels, unexpected pH swings, or even product variability showing up only after months of storage. The hydrochloride version avoids these traps, providing process scientists greater control and fewer last-minute corrections in protocol.
A chemical like this isn’t just about ticking boxes for assay and impurity. It teaches daily lessons in humility and continual improvement. Several times, genuine feedback from process chemists revealed limitations we overlooked in the lab. Whether it was a minor color change during scale up, unexpected mists in drum opening, or a question of how minor residuals shifted during storage, we learned to respect the information coming directly from the field.
Long-term relationships with customers forced us to keep our methods transparent and our quality systems continually updated. Our team now considers every kilo delivered as both a test and a lesson for the next. By aiming for continuous upgrade, we have stayed competitive not through aggressive cost cutting, but through demonstrable results and word-of-mouth from industry experts who track performance and document every hiccup.
Manufacturing Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride means turning structural complexity into daily, manageable process routines. It means learning where theory fails to predict practice, and investing in both people and systems to address the gaps. Our operation does not rely on secrets or shortcuts: we focus on clear traceability, direct feedback, and earnest dialogue with end-users whose workloads depend on dependable supply and support.
Industry changes do not threaten these principles. If anything, each new regulatory hurdle or technical demand sharpens our commitment. The years have shown us the irreplaceable value of transparency, responsiveness, and respect for the voice of those actually using the material. Instead of treating chemistry as a finished equation, we pull lessons forward from every batch, every delivery, and every real-world challenge.
Ethyl (2R,4R)-1-(Nitroglycerine-Nitro-L-Arginyl)-4-Methyl-Piperidinecarboxylate Hydrochloride is not just a product number. It is the result of hundreds of days’ worth of tuning, testing, and honest learning, backed by open channels to its users and a willingness to chase improvement rather than settle for “good enough.” Through this commitment, we continue to supply a compound that meets not just published specification, but the living, evolving demands of modern fine chemical production.